跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 3,144 条关于
“Enroll-HD”
全部
3,144
临床试验
800
药物
86
机构
1
资讯
2,257
去年
Beta-Blockers Linked to Delayed Onset and Slower Progression of Huntington's Disease
2年前
Skyhawk's SKY-0515 Shows Promise in Huntington's Disease with 72% HTT mRNA Reduction
去年
FDA Hears Directly From Huntington's Disease Community in Externally-Led Meeting
去年
Pridopidine Shows Promising Long-Term Benefits for Huntington's Disease Patients Not on Antidopaminergic Medications
2年前
VO659 Shows Promise in Reducing Mutant Huntingtin Protein in Huntington's Disease Patients
去年
PTC518 Shows Promise in Huntington's Disease: Phase 2 Trial Meets Primary Endpoint
3天前
Skyhawk's SKY-0515 Shows 1.59-Point cUHDRS Advantage at 15 Months in Huntington's Disease
2年前
Phase 2 Trial Assesses Felodipine Tolerability for Huntington's Disease
去年
Vabysmo Shows Superior CST Reduction Compared to Eylea HD in DME and nAMD: Meta-Analysis
去年
AVMA and Cornell University Launch Clinical Trial to Combat Veterinary Burnout
第 1 页,共 226 页
上一页
下一页